E’Ola Ephedrine Hydrochloride Sales Barred Under FDA Settlement
This article was originally published in The Tan Sheet
Executive Summary
FDA may order Biogenics, d/b/a E'Ola International, to "discontinue all manufacturing, processing, packing, labeling and distribution" if it believes the supplement marketer is selling a misbranded or adulterated product, according to a recent consent decree
You may also be interested in...
GMP Dispute Resolution System Under Development By FDA; PAT Is Impetus
FDA is planning to create a dispute resolution system for manufacturing inspections
E’Ola Ephedrine HCl Product Seized, FDA Complaint Alleges Item To Be Drug
Approximately 140,000 bottles of E'Ola International's AMP II Pro Drops, worth roughly $2.8 mil., were seized by U.S. Marshals Oct. 31
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC